about the author

Max Bayer

Pharma Reporter

mbayer@endpointsnews.com

author articles

FDA ap­proves Mod­er­na’s next-gen Covid vac­cine, with lim­its on most healthy peo­ple

11 hours ago
Pharma
FDA+

HHS says it's pulled Covid shot guid­ance for healthy kids. The CDC vac­cine sched­ule shows oth­er­wise

Yesterday
Pharma
FDA+

Q&A: Why for­mer Sen. Kyrsten Sine­ma is back­ing a psy­che­del­ic med­i­cine with po­ten­tial­ly more up­side, but more risk

Yesterday
People
R&D

Up­dat­ed: Trump ad­min­is­tra­tion halts more than $750M in funds for Mod­er­na’s bird flu vac­cine

3 days ago
Pharma
Coronavirus

The fate of Mod­er­na’s next-gen Covid shot looms large af­ter a flur­ry of pol­i­cy changes

3 days ago
R&D
FDA+

RFK Jr. ends an­nu­al Covid vac­cine rec­om­men­da­tions for kids, preg­nant women

4 days ago
FDA+

Gil­gamesh’s short-act­ing psy­che­del­ic drug shows rapid ef­fect in Phase 2 de­pres­sion study

4 days ago
R&D

Trump asks 'very tough hom­bre' Dr. Oz to lead MFN talks

Last week
Pharma

Volas­tra un­veils first hu­man da­ta of its sol­id tu­mor drug tar­get

Last week
R&D

Up­dat­ed: FDA ex­pects 'time­ly avail­abil­i­ty' of Covid shots as ad­vi­sors up­date for­mu­la rec­om­men­da­tion

Last week
FDA+
Coronavirus

The ‘MA­HA re­port’: Four key take­aways on vac­cines, med­i­cine and the phar­ma in­dus­try

Last week
Pharma
FDA+

FDA asks Covid vac­cine mak­ers to add more my­ocardi­tis da­ta to la­bels

Last week
Pharma
FDA+

Up­dat­ed: Eikon Ther­a­peu­tics cuts staff for the sec­ond time in less than two years

Last week
People

In his first ma­jor pol­i­cy roll­out, Vinay Prasad looks to chal­lenge ex­ist­ing 'dog­ma' on Covid vac­cines

Last week
R&D
FDA+

Makary, Prasad spell out FDA ground rules for fu­ture Covid vac­cine ap­provals

Last week
FDA+
Coronavirus

Up­dat­ed: FDA ap­proves No­vavax's Covid vac­cine af­ter six-week de­lay, but for a small­er pop­u­la­tion

Last week
Pharma
FDA+

RFK Jr. adopts new chikun­gun­ya vac­cine guid­ance; oth­er rec­om­men­da­tions re­main un­der re­view

3 weeks ago
R&D
Pharma

RFK Jr. says his opin­ions of vac­cines are ‘ir­rel­e­vant.’ For­mer FDA chief Califf dis­agrees

3 weeks ago
Pharma
FDA+

Up­dat­ed: White House threat­ens ‘most fa­vored na­tion’ plan to low­er US drug prices, but many ques­tions re­main

3 weeks ago
Pharma

Trump says he'll sign or­der on 'most fa­vored na­tion' drug price plans Mon­day

3 weeks ago
R&D
Pharma

FDA will con­vene vac­cine ad­vi­sors to dis­cuss Covid strain up­dates

4 weeks ago
Pharma
FDA+

From deal to dis­as­ter: Drug­mak­ers face a changed Wash­ing­ton as Trump em­braces ‘most fa­vored na­tion’ prices

4 weeks ago
Pharma

Even as ques­tions grow over RFK Jr.'s vac­cine pol­i­cy, BioN­Tech does­n't see ‘near-term’ im­pact

4 weeks ago
R&D
Pharma

White House bud­get re­quest would cut bil­lions at NIH and CDC, add $500M for MA­HA

5 weeks ago
Pharma
FDA+
1234 Next page Last page
A service from the Financial Times